The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Human Rabies Immunoglobulin (IM) Market Research Report 2023

Global Human Rabies Immunoglobulin (IM) Market Research Report 2023

Publishing Date : Jan, 2023

License Type :
 

Report Code : 1418965

No of Pages : 91

Ask Your Query

Synopsis
Rabies immunoglobulin (RIG) is a medication made up of antibodies against the rabies virus. It is used to prevent rabies following exposure.

Figure Human Rabies Immunoglobulin (IM) is rabies immunoglobulin antibody by the high price of healthy human plasma protein low temperature ethanol separation or other separation methods approved separation and purification, and by virus removal and inactivation treatment is made. Mainly used for rabies or other crazy animal bites, scratches patient's passive immunization.

In this report, we study ERIG (Equine Rabies Immunoglobulin) and HRIG (Human Rabies Immunoglobulin)

Highlights
The global Human Rabies Immunoglobulin (IM) market was valued at US$ 396 million in 2022 and is anticipated to reach US$ 606.3 million by 2029, witnessing a CAGR of 6.2% during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
Global Human Rabies Immunoglobulin (IM) key players include CSL Behring, Grifols, Sanofi, etc. Global top three manufacturers hold a share about 60%.
North America is the largest market, with a share over 30%, followed by China and Europe, both have a share about 45 percent.
In terms of product, HRIG is the largest segment, with a share over 85%. And in terms of application, the largest application is Category III Exposure, followed by Category II Exposure.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Human Rabies Immunoglobulin (IM), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Rabies Immunoglobulin (IM).
The Human Rabies Immunoglobulin (IM) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Human Rabies Immunoglobulin (IM) market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Rabies Immunoglobulin (IM) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.

By Company

  • Csl Behring
  • Grifols
  • Sanofi
  • Sichuan Yuanda Shuyang
  • Cnbg
  • Kamada
  • Cbpo
  • Shuanglin Bio
  • Weiguang Bio
  • Shanghai Raas
  • Bharat Serum
  • Vins

Segment by Type

  • ERIG
  • HRIG

Segment by Application

  • Category II Exposure
  • Category III Exposure

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina, Colombia)

Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Human Rabies Immunoglobulin (IM) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Human Rabies Immunoglobulin (IM) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Index

1 Human Rabies Immunoglobulin (IM) Market Overview
1.1 Product Overview and Scope of Human Rabies Immunoglobulin (IM)
1.2 Human Rabies Immunoglobulin (IM) Segment by Type
1.2.1 Global Human Rabies Immunoglobulin (IM) Market Value Comparison by Type (2023-2029)
1.2.2 ERIG
1.2.3 HRIG
1.3 Human Rabies Immunoglobulin (IM) Segment by Application
1.3.1 Global Human Rabies Immunoglobulin (IM) Market Value by Application: (2023-2029)
1.3.2 Category II Exposure
1.3.3 Category III Exposure
1.4 Global Human Rabies Immunoglobulin (IM) Market Size Estimates and Forecasts
1.4.1 Global Human Rabies Immunoglobulin (IM) Revenue 2018-2029
1.4.2 Global Human Rabies Immunoglobulin (IM) Sales 2018-2029
1.4.3 Global Human Rabies Immunoglobulin (IM) Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Human Rabies Immunoglobulin (IM) Market Competition by Manufacturers
2.1 Global Human Rabies Immunoglobulin (IM) Sales Market Share by Manufacturers (2018-2023)
2.2 Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Human Rabies Immunoglobulin (IM) Average Price by Manufacturers (2018-2023)
2.4 Global Human Rabies Immunoglobulin (IM) Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Human Rabies Immunoglobulin (IM), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Human Rabies Immunoglobulin (IM), Product Type & Application
2.7 Human Rabies Immunoglobulin (IM) Market Competitive Situation and Trends
2.7.1 Human Rabies Immunoglobulin (IM) Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Human Rabies Immunoglobulin (IM) Players Market Share by Revenue
2.7.3 Global Human Rabies Immunoglobulin (IM) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Human Rabies Immunoglobulin (IM) Retrospective Market Scenario by Region
3.1 Global Human Rabies Immunoglobulin (IM) Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Human Rabies Immunoglobulin (IM) Global Human Rabies Immunoglobulin (IM) Sales by Region: 2018-2029
3.2.1 Global Human Rabies Immunoglobulin (IM) Sales by Region: 2018-2023
3.2.2 Global Human Rabies Immunoglobulin (IM) Sales by Region: 2024-2029
3.3 Global Human Rabies Immunoglobulin (IM) Global Human Rabies Immunoglobulin (IM) Revenue by Region: 2018-2029
3.3.1 Global Human Rabies Immunoglobulin (IM) Revenue by Region: 2018-2023
3.3.2 Global Human Rabies Immunoglobulin (IM) Revenue by Region: 2024-2029
3.4 North America Human Rabies Immunoglobulin (IM) Market Facts & Figures by Country
3.4.1 North America Human Rabies Immunoglobulin (IM) Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Human Rabies Immunoglobulin (IM) Sales by Country (2018-2029)
3.4.3 North America Human Rabies Immunoglobulin (IM) Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Human Rabies Immunoglobulin (IM) Market Facts & Figures by Country
3.5.1 Europe Human Rabies Immunoglobulin (IM) Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Human Rabies Immunoglobulin (IM) Sales by Country (2018-2029)
3.5.3 Europe Human Rabies Immunoglobulin (IM) Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Human Rabies Immunoglobulin (IM) Market Facts & Figures by Country
3.6.1 Asia Pacific Human Rabies Immunoglobulin (IM) Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Human Rabies Immunoglobulin (IM) Sales by Country (2018-2029)
3.6.3 Asia Pacific Human Rabies Immunoglobulin (IM) Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Human Rabies Immunoglobulin (IM) Market Facts & Figures by Country
3.7.1 Latin America Human Rabies Immunoglobulin (IM) Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Human Rabies Immunoglobulin (IM) Sales by Country (2018-2029)
3.7.3 Latin America Human Rabies Immunoglobulin (IM) Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Human Rabies Immunoglobulin (IM) Market Facts & Figures by Country
3.8.1 Middle East and Africa Human Rabies Immunoglobulin (IM) Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Human Rabies Immunoglobulin (IM) Sales by Country (2018-2029)
3.8.3 Middle East and Africa Human Rabies Immunoglobulin (IM) Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Human Rabies Immunoglobulin (IM) Sales by Type (2018-2029)
4.1.1 Global Human Rabies Immunoglobulin (IM) Sales by Type (2018-2023)
4.1.2 Global Human Rabies Immunoglobulin (IM) Sales by Type (2024-2029)
4.1.3 Global Human Rabies Immunoglobulin (IM) Sales Market Share by Type (2018-2029)
4.2 Global Human Rabies Immunoglobulin (IM) Revenue by Type (2018-2029)
4.2.1 Global Human Rabies Immunoglobulin (IM) Revenue by Type (2018-2023)
4.2.2 Global Human Rabies Immunoglobulin (IM) Revenue by Type (2024-2029)
4.2.3 Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Type (2018-2029)
4.3 Global Human Rabies Immunoglobulin (IM) Price by Type (2018-2029)
5 Segment by Application
5.1 Global Human Rabies Immunoglobulin (IM) Sales by Application (2018-2029)
5.1.1 Global Human Rabies Immunoglobulin (IM) Sales by Application (2018-2023)
5.1.2 Global Human Rabies Immunoglobulin (IM) Sales by Application (2024-2029)
5.1.3 Global Human Rabies Immunoglobulin (IM) Sales Market Share by Application (2018-2029)
5.2 Global Human Rabies Immunoglobulin (IM) Revenue by Application (2018-2029)
5.2.1 Global Human Rabies Immunoglobulin (IM) Revenue by Application (2018-2023)
5.2.2 Global Human Rabies Immunoglobulin (IM) Revenue by Application (2024-2029)
5.2.3 Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Application (2018-2029)
5.3 Global Human Rabies Immunoglobulin (IM) Price by Application (2018-2029)
6 Key Companies Profiled
6.1 CSL Behring
6.1.1 CSL Behring Corporation Information
6.1.2 CSL Behring Description and Business Overview
6.1.3 CSL Behring Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2018-2023)
6.1.4 CSL Behring Human Rabies Immunoglobulin (IM) Product Portfolio
6.1.5 CSL Behring Recent Developments/Updates
6.2 Grifols
6.2.1 Grifols Corporation Information
6.2.2 Grifols Description and Business Overview
6.2.3 Grifols Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Grifols Human Rabies Immunoglobulin (IM) Product Portfolio
6.2.5 Grifols Recent Developments/Updates
6.3 Sanofi
6.3.1 Sanofi Corporation Information
6.3.2 Sanofi Description and Business Overview
6.3.3 Sanofi Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Sanofi Human Rabies Immunoglobulin (IM) Product Portfolio
6.3.5 Sanofi Recent Developments/Updates
6.4 Sichuan Yuanda Shuyang
6.4.1 Sichuan Yuanda Shuyang Corporation Information
6.4.2 Sichuan Yuanda Shuyang Description and Business Overview
6.4.3 Sichuan Yuanda Shuyang Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Sichuan Yuanda Shuyang Human Rabies Immunoglobulin (IM) Product Portfolio
6.4.5 Sichuan Yuanda Shuyang Recent Developments/Updates
6.5 CNBG
6.5.1 CNBG Corporation Information
6.5.2 CNBG Description and Business Overview
6.5.3 CNBG Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2018-2023)
6.5.4 CNBG Human Rabies Immunoglobulin (IM) Product Portfolio
6.5.5 CNBG Recent Developments/Updates
6.6 Kamada
6.6.1 Kamada Corporation Information
6.6.2 Kamada Description and Business Overview
6.6.3 Kamada Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Kamada Human Rabies Immunoglobulin (IM) Product Portfolio
6.6.5 Kamada Recent Developments/Updates
6.7 CBPO
6.6.1 CBPO Corporation Information
6.6.2 CBPO Description and Business Overview
6.6.3 CBPO Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2018-2023)
6.4.4 CBPO Human Rabies Immunoglobulin (IM) Product Portfolio
6.7.5 CBPO Recent Developments/Updates
6.8 Shuanglin Bio
6.8.1 Shuanglin Bio Corporation Information
6.8.2 Shuanglin Bio Description and Business Overview
6.8.3 Shuanglin Bio Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Shuanglin Bio Human Rabies Immunoglobulin (IM) Product Portfolio
6.8.5 Shuanglin Bio Recent Developments/Updates
6.9 Weiguang Bio
6.9.1 Weiguang Bio Corporation Information
6.9.2 Weiguang Bio Description and Business Overview
6.9.3 Weiguang Bio Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Weiguang Bio Human Rabies Immunoglobulin (IM) Product Portfolio
6.9.5 Weiguang Bio Recent Developments/Updates
6.10 Shanghai RAAS
6.10.1 Shanghai RAAS Corporation Information
6.10.2 Shanghai RAAS Description and Business Overview
6.10.3 Shanghai RAAS Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Shanghai RAAS Human Rabies Immunoglobulin (IM) Product Portfolio
6.10.5 Shanghai RAAS Recent Developments/Updates
6.11 Bharat Serum
6.11.1 Bharat Serum Corporation Information
6.11.2 Bharat Serum Human Rabies Immunoglobulin (IM) Description and Business Overview
6.11.3 Bharat Serum Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Bharat Serum Human Rabies Immunoglobulin (IM) Product Portfolio
6.11.5 Bharat Serum Recent Developments/Updates
6.12 VINS
6.12.1 VINS Corporation Information
6.12.2 VINS Human Rabies Immunoglobulin (IM) Description and Business Overview
6.12.3 VINS Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2018-2023)
6.12.4 VINS Human Rabies Immunoglobulin (IM) Product Portfolio
6.12.5 VINS Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Human Rabies Immunoglobulin (IM) Industry Chain Analysis
7.2 Human Rabies Immunoglobulin (IM) Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Human Rabies Immunoglobulin (IM) Production Mode & Process
7.4 Human Rabies Immunoglobulin (IM) Sales and Marketing
7.4.1 Human Rabies Immunoglobulin (IM) Sales Channels
7.4.2 Human Rabies Immunoglobulin (IM) Distributors
7.5 Human Rabies Immunoglobulin (IM) Customers
8 Human Rabies Immunoglobulin (IM) Market Dynamics
8.1 Human Rabies Immunoglobulin (IM) Industry Trends
8.2 Human Rabies Immunoglobulin (IM) Market Drivers
8.3 Human Rabies Immunoglobulin (IM) Market Challenges
8.4 Human Rabies Immunoglobulin (IM) Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Tables

List of Tables
Table 1. Global Human Rabies Immunoglobulin (IM) Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Human Rabies Immunoglobulin (IM) Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Human Rabies Immunoglobulin (IM) Market Competitive Situation by Manufacturers in 2022
Table 4. Global Human Rabies Immunoglobulin (IM) Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Human Rabies Immunoglobulin (IM) Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Human Rabies Immunoglobulin (IM) Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Human Rabies Immunoglobulin (IM) Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Human Rabies Immunoglobulin (IM) Average Price (USD/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Human Rabies Immunoglobulin (IM), Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Human Rabies Immunoglobulin (IM), Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Human Rabies Immunoglobulin (IM), Product Type & Application
Table 12. Global Key Manufacturers of Human Rabies Immunoglobulin (IM), Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Human Rabies Immunoglobulin (IM) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Rabies Immunoglobulin (IM) as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Human Rabies Immunoglobulin (IM) Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Human Rabies Immunoglobulin (IM) Sales by Region (2018-2023) & (K Units)
Table 18. Global Human Rabies Immunoglobulin (IM) Sales Market Share by Region (2018-2023)
Table 19. Global Human Rabies Immunoglobulin (IM) Sales by Region (2024-2029) & (K Units)
Table 20. Global Human Rabies Immunoglobulin (IM) Sales Market Share by Region (2024-2029)
Table 21. Global Human Rabies Immunoglobulin (IM) Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Region (2018-2023)
Table 23. Global Human Rabies Immunoglobulin (IM) Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Region (2024-2029)
Table 25. North America Human Rabies Immunoglobulin (IM) Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Human Rabies Immunoglobulin (IM) Sales by Country (2018-2023) & (K Units)
Table 27. North America Human Rabies Immunoglobulin (IM) Sales by Country (2024-2029) & (K Units)
Table 28. North America Human Rabies Immunoglobulin (IM) Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Human Rabies Immunoglobulin (IM) Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Human Rabies Immunoglobulin (IM) Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Human Rabies Immunoglobulin (IM) Sales by Country (2018-2023) & (K Units)
Table 32. Europe Human Rabies Immunoglobulin (IM) Sales by Country (2024-2029) & (K Units)
Table 33. Europe Human Rabies Immunoglobulin (IM) Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Human Rabies Immunoglobulin (IM) Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Human Rabies Immunoglobulin (IM) Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Human Rabies Immunoglobulin (IM) Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Human Rabies Immunoglobulin (IM) Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Human Rabies Immunoglobulin (IM) Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Human Rabies Immunoglobulin (IM) Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Human Rabies Immunoglobulin (IM) Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Human Rabies Immunoglobulin (IM) Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Human Rabies Immunoglobulin (IM) Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Human Rabies Immunoglobulin (IM) Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Human Rabies Immunoglobulin (IM) Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Human Rabies Immunoglobulin (IM) Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Human Rabies Immunoglobulin (IM) Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Human Rabies Immunoglobulin (IM) Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Human Rabies Immunoglobulin (IM) Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Human Rabies Immunoglobulin (IM) Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Human Rabies Immunoglobulin (IM) Sales (K Units) by Type (2018-2023)
Table 51. Global Human Rabies Immunoglobulin (IM) Sales (K Units) by Type (2024-2029)
Table 52. Global Human Rabies Immunoglobulin (IM) Sales Market Share by Type (2018-2023)
Table 53. Global Human Rabies Immunoglobulin (IM) Sales Market Share by Type (2024-2029)
Table 54. Global Human Rabies Immunoglobulin (IM) Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Human Rabies Immunoglobulin (IM) Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Type (2018-2023)
Table 57. Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Type (2024-2029)
Table 58. Global Human Rabies Immunoglobulin (IM) Price (USD/Unit) by Type (2018-2023)
Table 59. Global Human Rabies Immunoglobulin (IM) Price (USD/Unit) by Type (2024-2029)
Table 60. Global Human Rabies Immunoglobulin (IM) Sales (K Units) by Application (2018-2023)
Table 61. Global Human Rabies Immunoglobulin (IM) Sales (K Units) by Application (2024-2029)
Table 62. Global Human Rabies Immunoglobulin (IM) Sales Market Share by Application (2018-2023)
Table 63. Global Human Rabies Immunoglobulin (IM) Sales Market Share by Application (2024-2029)
Table 64. Global Human Rabies Immunoglobulin (IM) Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Human Rabies Immunoglobulin (IM) Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Application (2018-2023)
Table 67. Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Application (2024-2029)
Table 68. Global Human Rabies Immunoglobulin (IM) Price (USD/Unit) by Application (2018-2023)
Table 69. Global Human Rabies Immunoglobulin (IM) Price (USD/Unit) by Application (2024-2029)
Table 70. CSL Behring Corporation Information
Table 71. CSL Behring Description and Business Overview
Table 72. CSL Behring Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 73. CSL Behring Human Rabies Immunoglobulin (IM) Product
Table 74. CSL Behring Recent Developments/Updates
Table 75. Grifols Corporation Information
Table 76. Grifols Description and Business Overview
Table 77. Grifols Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 78. Grifols Human Rabies Immunoglobulin (IM) Product
Table 79. Grifols Recent Developments/Updates
Table 80. Sanofi Corporation Information
Table 81. Sanofi Description and Business Overview
Table 82. Sanofi Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 83. Sanofi Human Rabies Immunoglobulin (IM) Product
Table 84. Sanofi Recent Developments/Updates
Table 85. Sichuan Yuanda Shuyang Corporation Information
Table 86. Sichuan Yuanda Shuyang Description and Business Overview
Table 87. Sichuan Yuanda Shuyang Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 88. Sichuan Yuanda Shuyang Human Rabies Immunoglobulin (IM) Product
Table 89. Sichuan Yuanda Shuyang Recent Developments/Updates
Table 90. CNBG Corporation Information
Table 91. CNBG Description and Business Overview
Table 92. CNBG Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 93. CNBG Human Rabies Immunoglobulin (IM) Product
Table 94. CNBG Recent Developments/Updates
Table 95. Kamada Corporation Information
Table 96. Kamada Description and Business Overview
Table 97. Kamada Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 98. Kamada Human Rabies Immunoglobulin (IM) Product
Table 99. Kamada Recent Developments/Updates
Table 100. CBPO Corporation Information
Table 101. CBPO Description and Business Overview
Table 102. CBPO Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 103. CBPO Human Rabies Immunoglobulin (IM) Product
Table 104. CBPO Recent Developments/Updates
Table 105. Shuanglin Bio Corporation Information
Table 106. Shuanglin Bio Description and Business Overview
Table 107. Shuanglin Bio Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 108. Shuanglin Bio Human Rabies Immunoglobulin (IM) Product
Table 109. Shuanglin Bio Recent Developments/Updates
Table 110. Weiguang Bio Corporation Information
Table 111. Weiguang Bio Description and Business Overview
Table 112. Weiguang Bio Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 113. Weiguang Bio Human Rabies Immunoglobulin (IM) Product
Table 114. Weiguang Bio Recent Developments/Updates
Table 115. Shanghai RAAS Corporation Information
Table 116. Shanghai RAAS Description and Business Overview
Table 117. Shanghai RAAS Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 118. Shanghai RAAS Human Rabies Immunoglobulin (IM) Product
Table 119. Shanghai RAAS Recent Developments/Updates
Table 120. Bharat Serum Corporation Information
Table 121. Bharat Serum Description and Business Overview
Table 122. Bharat Serum Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 123. Bharat Serum Human Rabies Immunoglobulin (IM) Product
Table 124. Bharat Serum Recent Developments/Updates
Table 125. VINS Corporation Information
Table 126. VINS Description and Business Overview
Table 127. VINS Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 128. VINS Human Rabies Immunoglobulin (IM) Product
Table 129. VINS Recent Developments/Updates
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. Human Rabies Immunoglobulin (IM) Distributors List
Table 133. Human Rabies Immunoglobulin (IM) Customers List
Table 134. Human Rabies Immunoglobulin (IM) Market Trends
Table 135. Human Rabies Immunoglobulin (IM) Market Drivers
Table 136. Human Rabies Immunoglobulin (IM) Market Challenges
Table 137. Human Rabies Immunoglobulin (IM) Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Human Rabies Immunoglobulin (IM)
Figure 2. Global Human Rabies Immunoglobulin (IM) Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Human Rabies Immunoglobulin (IM) Market Share by Type in 2022 & 2029
Figure 4. ERIG Product Picture
Figure 5. HRIG Product Picture
Figure 6. Global Human Rabies Immunoglobulin (IM) Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Human Rabies Immunoglobulin (IM) Market Share by Application in 2022 & 2029
Figure 8. Category II Exposure
Figure 9. Category III Exposure
Figure 10. Global Human Rabies Immunoglobulin (IM) Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 11. Global Human Rabies Immunoglobulin (IM) Market Size (2018-2029) & (US$ Million)
Figure 12. Global Human Rabies Immunoglobulin (IM) Sales (2018-2029) & (K Units)
Figure 13. Global Human Rabies Immunoglobulin (IM) Average Price (USD/Unit) & (2018-2029)
Figure 14. Human Rabies Immunoglobulin (IM) Report Years Considered
Figure 15. Human Rabies Immunoglobulin (IM) Sales Share by Manufacturers in 2022
Figure 16. Global Human Rabies Immunoglobulin (IM) Revenue Share by Manufacturers in 2022
Figure 17. The Global 5 and 10 Largest Human Rabies Immunoglobulin (IM) Players: Market Share by Revenue in 2022
Figure 18. Human Rabies Immunoglobulin (IM) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 19. Global Human Rabies Immunoglobulin (IM) Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 20. North America Human Rabies Immunoglobulin (IM) Sales Market Share by Country (2018-2029)
Figure 21. North America Human Rabies Immunoglobulin (IM) Revenue Market Share by Country (2018-2029)
Figure 22. U.S. Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 23. Canada Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Europe Human Rabies Immunoglobulin (IM) Sales Market Share by Country (2018-2029)
Figure 25. Europe Human Rabies Immunoglobulin (IM) Revenue Market Share by Country (2018-2029)
Figure 26. Germany Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. France Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. U.K. Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. Italy Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Russia Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Asia Pacific Human Rabies Immunoglobulin (IM) Sales Market Share by Region (2018-2029)
Figure 32. Asia Pacific Human Rabies Immunoglobulin (IM) Revenue Market Share by Region (2018-2029)
Figure 33. China Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Japan Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. South Korea Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. India Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Australia Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. China Taiwan Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Indonesia Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Thailand Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Malaysia Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Philippines Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Latin America Human Rabies Immunoglobulin (IM) Sales Market Share by Country (2018-2029)
Figure 44. Latin America Human Rabies Immunoglobulin (IM) Revenue Market Share by Country (2018-2029)
Figure 45. Mexico Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Brazil Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Argentina Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Middle East & Africa Human Rabies Immunoglobulin (IM) Sales Market Share by Country (2018-2029)
Figure 49. Middle East & Africa Human Rabies Immunoglobulin (IM) Revenue Market Share by Country (2018-2029)
Figure 50. Turkey Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Saudi Arabia Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. U.A.E Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Global Sales Market Share of Human Rabies Immunoglobulin (IM) by Type (2018-2029)
Figure 54. Global Revenue Market Share of Human Rabies Immunoglobulin (IM) by Type (2018-2029)
Figure 55. Global Human Rabies Immunoglobulin (IM) Price (USD/Unit) by Type (2018-2029)
Figure 56. Global Sales Market Share of Human Rabies Immunoglobulin (IM) by Application (2018-2029)
Figure 57. Global Revenue Market Share of Human Rabies Immunoglobulin (IM) by Application (2018-2029)
Figure 58. Global Human Rabies Immunoglobulin (IM) Price (USD/Unit) by Application (2018-2029)
Figure 59. Human Rabies Immunoglobulin (IM) Value Chain
Figure 60. Human Rabies Immunoglobulin (IM) Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock